AntriaBio (ANTE) has no currently recruiting or active clinical trials where it is listed as lead sponsor on ClinicalTrials.gov.
ANTE has 1 Form 4 insider filing recorded at the SEC in the past 30 days[1].
Sources
- SEC EDGAR (2026-04-11) ↗
ANTE is tracked by BiotechSigns with a current catalyst score of 92/100 and grade A. The page summarizes 0 active signals, including 0 PDUFA, 0 insider buying, and 0 clinical trial signals, with data refreshed on 2026-06-03.
AntriaBio (ANTE) has no currently recruiting or active clinical trials where it is listed as lead sponsor on ClinicalTrials.gov.
ANTE has 1 Form 4 insider filing recorded at the SEC in the past 30 days[1].